Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases from Colorectal Cancer?

Annals of Surgery

Volumn 261, Issue 5, 2015, Pages 956-960

  Dueland, Svein ^a   Guren, Tormod K ^a   Hagness, Morten ^a,b   Glimelius, Bengt ^c   Line, Pål Dag ^a   Pfeiffer, Per ^d   Foss, Aksel ^a,b   Tveit, Kjell M ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UPPSALA UNIVERSITY   (Sweden)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

chemotherapy; colorectal cancer; liver metastases; liver transplantation; overall survival

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN;

BLOOD; CLINICAL TRIAL; COLORECTAL TUMOR; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; HUMAN; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MULTICENTER STUDY; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SECONDARY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84958163428     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000786     Document Type: Article

References (22)

1. Kanas GP, Taylor A, Primrose JN, Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012; 4: 283-301.
2. Masi G, Vasile E, Loupakis F, Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis. J Natl Cancer Inst. 2011; 103: 21-30.
3. Van Cutsem E, Kohne CH, Hitre E, Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009; 360: 1408-1417.
4. Glimelius B, Cavalli-Bjørkman N,. Metastatic colorectal cancer: current treatment and future options for improved survival. Scand J Gastroenerol. 2012; 47: 296-314.
5. Van Cutsem E, Kohne CH, Lang I, Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol. 2011; 29: 2011-2019.
6. Douillard JY, Siena S, Cassidy J, Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol. 2010; 28: 4697-4705.
7. Hoti E, Adam R,. Liver transplantation for primary and metastatic liver cancers. Transpl Int. 2008; 21: 1107-1117.
8. Mazzaferro V, Llovet JM, Miceli R, Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009; 10: 35-43.
9. Muhlbacher F, Huk I, Steininger R, Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver? Transplant Proc. 1991; 23: 1567-1568.
10. Hagness M, Foss A, Line PD, Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg. 2013; 257: 800-806.
11. Tveit KM, Guren T, Glimelius B, Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study. J Clin Oncol. 2012; 30: 1755-1762.
12. Sobrero AF, Maurel J, Fehrenbacher L, EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer. J Clin Oncol. 2008; 26: 2311-2319.
13. Giantonio BJ, Catalano PJ, Meropol NJ, Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol. 2007; 25: 1539-1544.
14. Peeters M, Price TJ, Cervantes A, Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol. 2010; 28: 4706-4713.
15. Nordlinger B, Sorbye H, Glimelius B, Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008; 371: 1007-1016.
16. Nordlinger B, Sorbye H, Glimelius B, Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013; 14: 1208-1215.
17. Brudvik KW, Bains SJ, Seeberg LT, Aggressive treatment of patients with metastatic colorectal cancer increases survival: a Scandinavian single-center experience. HPB Surg. 2013; 2013.
18. Adam R, Pascal G, Castaing D, Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004; 240: 1052-1061.
19. Quan D, Gallinger S, Nhan C, The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery. 2012; 151: 860-870.
20. Fernandez FG, Drebin JA, Linehan DC, Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg. 2004; 240: 438-447.
21. Mazzaferro V, Bhoori S, Sposito C, Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl. 2011; 17 (Suppl 2): S44-S57.
22. Martins PNA, Movahedi B, Bozorgzadeh A,. Liver transplantation for unresectable colorectal cancer liver metastases: a paradigm change?. Ann Surg. 2014 May 15. [Epub ahead of print]